Question 1: Imagine you are a scientist working in an immunology lab and you are studying a new virus that is similar to Influenza virus that can activate CTL immune response. Your job is to study the epitopes in the viral spike protein and understand which epitope can generate a potent immune response. You would like to then use this data to formulate a vaccine for the virus. Answer the following questions based on your knowledge of CTL immune response, infectious diseases and vaccination. a) Design an experiment that you can use to study the various epitope peptides of the antigen on activating a CTL immune response. (Hint: Pulsing) b) Create a hypothetical data table to show which peptide resulted in effective lysis by CTL cells (Hint: Refer to the end of Chapter 12). c) Based on the data you have created, which peptide effectively resulted in lysis. d) How would you go about designing a vaccine using the epitope peptides you have designed? Talk about the methods, trials and safety considerations while designing the vaccine. e) What are the steps to consider before the vaccine is approved for use in humans?

Question 1: Imagine you are a scientist working in an immunology lab and you are studying a new virus that is similar to Influenza virus that can activate CTL immune response. Your job is to study the epitopes in the viral spike protein and understand which epitope can generate a potent immune response. You would like to then use this data to formulate a vaccine for the virus. Answer the following questions based on your knowledge of CTL immune response, infectious diseases and vaccination. a) Design an experiment that you can use to study the various epitope peptides of the antigen on activating a CTL immune response. (Hint: Pulsing) b) Create a hypothetical data table to show which peptide resulted in effective lysis by CTL cells (Hint: Refer to the end of Chapter 12). c) Based on the data you have created, which peptide effectively resulted in lysis. d) How would you go about designing a vaccine using the epitope peptides you have designed? Talk about the methods, trials and safety considerations while designing the vaccine. e) What are the steps to consider before the vaccine is approved for use in humans?

Principles Of Pharmacology Med Assist

6th Edition

ISBN:9781337512442

Author:RICE

Publisher:RICE

Chapter16: Antifungal, Antiviral, And Immunizing Agents

Section: Chapter Questions

Problem 8RQ

See similar textbooks

Similar questions

I am having a hard time digesting this article https://www.sciencedaily.com/releases/2016/04/160429095038.htm to answer the following questions Summarize the article in 4-6 bullet points. How does this article relate to the information you've read/watched in Module 2? Discuss in detail /reflect on info from textbook, articles, videos about our immune system and our gut microbes. Does your chosen autoimmunity article involve the innate immune system or the adaptive immune system? or both?- Explain.
Question 2 : Consider a disease for which only 25% of individuals who have become exposed are progressing to become infectious. However, whether or not an individual becomes infectious can only be determined after a 5-day latent period. Individuals who are not progressing to become infectious will remain susceptible. The average time an individual stays infective is 2 days. Also, after an average of 10 days after having recovered, 10% of recovered individuals will revert to become susceptible again. 90% of the individuals, however, acquire lifelong immunity. (a) Develop the transition diagram that depicts the move of individuals between compartments. Hint: you can use PowerPoint or online tool such as https://app.diagrams.net/ to draw the diagram. The diagram should contain the labels of the stages and have arrows indicating from one stage to another stage. ******Susceptible, invectives, and recovered individuals in the SIR model are moving through "the compartments " S-I-R.…
Question 72 The hepatitis B vaccine is an example of which type of vaccine? Question 72 options: a) A genetically engineered subunit vaccine b) An inactivated whole cell vaccine c) A toxoid vaccine d) An attenuated whole cell vaccine
Question 38 The constant region of each heavy chain determines the class of the heavy chain. Question 38 options: True False Question 39 The extensive variety of MHC proteins is apparent at a population level. Question 39 options: True False Question 40 the immunoglobulin sequences involved in antigen binding is situated in: Question 40 options: The constant region of the antibody The hyper-variable region of the antibody C terminal of the antibody Area close to disulfide bridges
question: Can you summarize and explain for me what you want to tell in the article below? When I read it myself, I do not understand exactly what is meant by the article. It would be nice if you could highlight the important points. You can use them in a figure or diagram to explain. thank you and hava a nice day :) Article: Photodynamic Inactivation of SARS-CoV-2 In addition to drug- and vaccine-based antiviral strategies, photodynamic therapy (PDT) stands as a unique approach to inactivate SARS-CoV-2. Using a light-based method, PDT attacks target cells via the excitation of photosensitive agents, called photosensitizers (PSs), with radiation characterized by a wavelength corresponding to its absorption spectrum to generate reactive oxygen species (ROS) in the presence of oxygen, which ultimately results in cell death. Photodynamic therapy is primarily used for the clinical treatment of various oncological disorders. It was not until the 1970s that PDT was first used clinically…
Question 77 Which of the following statements represents an advantage of passive immunization? Question 77 options: a) Passive immunization provides life-long immunity b) Passive immunization provides immediate protection against the pathogen c) Passive immunization stimulates the immune system d) Passive immunization induces a robust herd immunity
Jane Doe is infected with HIV. One of her medications is acyclovir, which is a/an_____________drug used to treat viral infections or to provide temporary immunity
question 1: what are 2 good potential targets in SARS-CoV2 virus to stop it from functioning ? (HINT: Think antibodies targeting important viral proteins) question 2: what is the Pfizer Vaccine composed of ? what does it target in SARS-CoV2 virus ? Can you connect it to any concept from Ch 17 in your course ?
Question:- Friend #1 was unfortunately stabbed with a scalpel by a stressed out fellow gross anatomy student in the neck (but lived!). Friend #2 underwent surgery to remove some lymph nodes in the cervical region VERY infected with an atypical Mycobacterium. Friend #2 wants to understand the mechanistic reason why his scar is so much worse than Friend #1's scar. Explain the difference to him. Do you think the scar would look better (i.e. the wound heal "better") if friend #2 underwent hyperbaric oxygen therapy? Justify your answer.
Antibodies play a critical role in the prevention of infection by the specific viruses the antibody is designed to detect. Which immune system cell produces antibodies? Indicate four ways that antibodies can disrupt the ability of a virus to infect a cell. PLEASE ANSWER ALL PARTS TO THIS QUESTION
Question 74 A patient's serology results report the presence of antibodies against diphtheria toxin. Which of the following statements is INCORRECT? Question 74 options: a) The patient may have the disease b) The patient may have been immunized c) The patient may have had the disease and has recovered d) The patient has not had the disease or received the vaccine
First question Based on the given picture, answer the following questions (5 ,6 and 7). How will you describe sample #5 and sample #2 in terms of immunological identity a. Non-identical. b. Partially identical. c. We cannot give a conclusion about 5 and 2. d. Identical. Second question How will you describe sample #1 and sample #2 in terms of immunological identity? a. Identical. b. Non-identical. c. Partially identical.